Aakash Educational Services Limited (AESL) Flagship Program ANTHE 2025 Tagline – Empowering Students to Become Problem Solvers of Tomorrow; Scholarships upto 100% Worth ₹250 Crore and Cash Awards Worth ₹2.5 Crore Announced for Students of…
MUMBAI, 30 JULY, 2025 (GPN): In a significant move towards strengthening cross-border capital flows, India’s top investors, family offices, and wealth professionals will convene in Mumbai this August for the inaugural edition of Manzil Majlis,…
HYDERABAD, 30th JULY, 2025 (GPN): AbhiBus (ixigo’s bus business), one of India’s leading online bus ticketing platforms, has introduced an industry-first filter – ‘New Buses’. This filter lets travellers easily identify and book newer buses during…
IIJS Premiere set to drive ₹70,000 crore in business over the next quarter FTAs Unlocking New Growth Opportunities for India’s Gem & Jewellery Industry: GJEPC Chairman Kirit Bhansali IIJS Premiere 2025 show dates: 30 July-3…
End-O Check will provide risk-based assessments, diagnostic testing, and symptom evaluation for women, particularly those in the postmenopausal age group NAVI MUMBAI, 30 JULY 2025 (GPN): Reinforcing its commitment to preventive oncology for women, Apollo…
Price band fixed at Rs. 760 to Rs. 800 per Equity Share of face value of Rs. 2 each (“Equity Share”) Bid Offer will open on Wednesday, July 30, 2025 and close on Friday, August…
Price Band fixed at Rs. 640 to Rs. 675 per equity share of face value of ₹ Rs. 1 each (“Equity Share”); Bid /Offer will open on Tuesday, July 29, 2025 and close on Thursday, July 31, 2025….
RHP: https://www.mnclgroup.com/storage/sri-lotus-rhp.pdf MUMBAI, JULY 24, 2025 (GPN): Sri Lotus Developers and Realty Limited has fixed the price band of Rs. 140/- to Rs. 150/- per Equity Share of face value Rs. 1/- each for its maiden initial…
MUMBAI, 23rd JULY, 2025 (GPN) – Mumbai is always on the move. Fast, driven, and full of life, the city is built for momentum. Today, that movement takes a powerful new turn with the launch…
Apollo Navi Mumbai embarks on an innovative ‘living drug’ treatment, This milestone achievement offers new hope to patients battling refractory B-cell lymphomas and acute B-cell lymphoblastic leukemia NAVI MUMBAI, 23 JULY 2025 (GPN) — Apollo…
